Dr Laith Al-Rubaiy

Consultant Gastroenterologist and Hepatologist

Dr Laith Al-Rubaiy is a Consultant Physician, Gastroenterologist and Hepatologist at St Mark’s Hospital in London. He is an Honorary Senior Clinical Lecturer, Imperial College School of Medicine, London University. He has been awarded the Young Gastroenterologist of the year in 2017 by the British Society of Gastroenterology for his clinical work, research, medical education and collaborations.

Recent Patient Feedback
“Excellent bedside manners. Dr Al-Rubaiy has explained my condition very well and answered all my questions. I would definately recommend him and I would come to see him in the future if needed.”

GMC Number: 6138133
Secretary: Ms Abi Anbar
Email: al-rubaiysec@gidoctors.co.uk
Telephone: 0203 6339 424

Surgery Locations:

 

The St Mark’s Private Healthcare,
Trust Plus, Northwick Park Hospital,
Watford Road, Harrow, HA1 3UJ
Click for Directions

The Clementine Churchill Hospital
Sudbury Hill,
Harrow, HA1 3RX
Click for Directions

The Pheonix Hospital Group
9 Harley Street,
London W1G 9QY
Click for Directions

Dr Laith Al-Rubaiy is a London based Consultant Gastroenterologist & Hepatologist. He is a clinical academic consultant and qualified in managing all aspects of gastroenterology and liver conditions.

 

Areas of expertise:

Alcoholic liver disease, Problems with the Pancreas and malabsorption, Irritable Bowel Disease, Inflmmatory Bowel disease, Acid reflux , gastritis, gastric or duodenal ulcer disease, Fatty liver disease, Diverticular bowel disease, viral hepatitis, Autoimmune liver disease, Liver cirrhosis, Chronic liver disease ,Endoscopy and Colonoscopy.

In practice:

Dr Laith Al-Rubaiy’s clinical work is based at St Mark’s hospital. He manages patients with various liver and bile ducts problems and other gastroenterology problems such as Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), diarrhoea, weight loss, anaemia and acid reflux disease. He performs and trains upper and lower gastrointestinal endoscopy to investigate these conditions.

Training:

1. PhD in developing patients reported outcome measures to support the care of patients in gastroenterology.
2. European Board certified in Gastroenterology and Hepatology
3. Advanced hepatology and liver transplant training at the Royal Free Hospital in London
4. Fellowship of the Royal College of Physicians in London

Research, publications and awards:

Dr Al-Rubaiy is an award winning doctor. He has been awarded 3 competitive national and local awards for my work in Gastroenterology and Hepatology. He has also been awarded 12 funding grants and 2 highly competitive scholarships throughout his career in the USA and UK. His current research is focused on developing and applying patients reported outcomes measures (PROMs) in Hepatology and Gastroenterology. He is a reviewer for a number of international journals and grant funding bodies and an author on several peer-reviewed publications. Some of his latest publications are:

1. Benmassaoud A, Alrubaiy L, et al . A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia. Aliment Pharmacol Ther. 2019 Nov;50(9):1049-1058.

2. Alrubaiy L, et al. PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis. Aliment Pharmacol Ther. 2019 Dec;50(11-12):1223-1231.

3. Clement C, Rapport F, Seagrove A, Alrubaiy L, Williams J. Healthcare professionals’ views of the use and administration of two salvage therapy drugs for acute ulcerative colitis: a nested qualitative study within the CONSTRUCT trial. BMJ Open. 2017 Feb 22;7(2):e014512. doi: 10.1136/bmjopen-2016-014512.

4. Alrubaiy L, et al Protocol for a prospective multicentre cohort study to develop and validate two new outcome measures for patients with inflammatory bowel disease. BMJ Open. 2013 Jul 9;3(7). pii: e003192. doi: 10.1136/bmjopen-2013-003192. Print 2013. PubMed PMID: 23842503;

5. Williams JG, Alam MF, Alrubaiy L, et al. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT). Health Technol Assess. 2016 Jun;20(44):1-320. doi: 10.3310/hta20440.

6. Hutchings HA, Cheung WY, Alrubaiy L, et al. Development and validation of the Gastrointestinal Endoscopy Satisfaction Questionnaire (GESQ). Endoscopy. 2015 Dec;47(12):1137-43.

Dr Laith Al-Rubaiy on YouTube

Inflammatory Bowel Disease (IBD)

Primary Sclerosing Cholangitis (PSC)

Primary Biliary Cholangitis (PBC)

Irritable Bowel Syndrome (IBS)

Non-alcoholic Liver Disease (NAFLD)

Autoimmune Hepatitis

Liver Fibroscan

Alcohol Related Liver Disease

Your health is our goal

Whether your gastrointestinal symptoms started recently or are long-standing, our specialists can help diagnose and manage your condition. Please contact us to arrange a consultation with one of our specialist team. A consultation with a specialist to discuss the necessary diagnostic tests is the first step.